Jazz Pharmaceuticals plc — Director's Dealing 2015

Sep 29, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-09-25

Reporting Person: MILLER MICHAEL PATRICK (SVP, US Commercial)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-25	Ordinary Shares	S	100.0	$145.23	Disposed	13890	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 69 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.